{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T23:10:27Z","timestamp":1719011427673},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,1,18]],"date-time":"2017-01-18T00:00:00Z","timestamp":1484697600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s12253-016-0160-8","type":"journal-article","created":{"date-parts":[[2017,1,18]],"date-time":"2017-01-18T18:08:45Z","timestamp":1484762925000},"page":"829-835","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Antitumor Efficacy of SLPI Promoter-Controlled Expression of Artificial microRNA Targeting EGFR in a Squamous Cell Carcinoma Cell Line"],"prefix":"10.1007","volume":"23","author":[{"given":"Jia","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoude","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beibei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,18]]},"reference":[{"key":"160_CR1","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJM200103293441306","volume":"344","author":"M Alam","year":"2001","unstructured":"Alam M, Ratner D (2001) Cutaneous squamous-cell carcinoma. N Engl J Med 344:975\u2013983","journal-title":"N Engl J Med"},{"key":"160_CR2","first-page":"275","volume":"1","author":"W Yan","year":"2011","unstructured":"Yan W, Wistuba II, Emmert-Buck MR, Erickson HS (2011) Squamous cell carcinoma \u2013 similarities and differences among anatomical sites. Am J Cancer Res 1:275\u2013300","journal-title":"Am J Cancer Res"},{"key":"160_CR3","doi-asserted-by":"crossref","first-page":"596","DOI":"10.6004\/jnccn.2011.0053","volume":"9","author":"DG Pfister","year":"2011","unstructured":"Pfister DG, Ang KK, Brizel DM et al (2011) Head and neck cancers. J Natl Compr Cancer Netw 9:596\u2013650","journal-title":"J Natl Compr Cancer Netw"},{"key":"160_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hed.21294","volume":"32","author":"KD Olsen","year":"2010","unstructured":"Olsen KD (2010) Reexamining the treatment of advanced laryngeal cancer. Head Neck 32:1\u20137","journal-title":"Head Neck"},{"key":"160_CR5","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00228-011-1194-1","volume":"68","author":"S Zhang","year":"2012","unstructured":"Zhang S, Chen J, Jiang H, MA H, Yang B (2012) Anti-epidermal growth factor receptor therapy for advanced head and neck squamous cell carcinoma: a meta-analysis. Eur J Clin Pharmacol 68:561\u2013569","journal-title":"Eur J Clin Pharmacol"},{"key":"160_CR6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","volume":"354","author":"JA Bonner","year":"2006","unstructured":"Bonner JA, Harari PM, Giralt J et al (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354:567\u2013578","journal-title":"N Engl J Med"},{"key":"160_CR7","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa0802656","volume":"359","author":"JB Vermorken","year":"2008","unstructured":"Vermorken JB, Mesia R, Rivera F et al (2008) Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 359:1116\u20131127","journal-title":"N Engl J Med"},{"key":"160_CR8","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1258\/ebm.2009.009181","volume":"235","author":"C Moon","year":"2010","unstructured":"Moon C, Chae YK, Lee J (2010) Targeting epidermal growth factor receptor in head and neck cancer: lessons learned from cetuximab. Exp Biol Med (Maywood) 235:907\u2013920","journal-title":"Exp Biol Med (Maywood)"},{"key":"160_CR9","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrclinonc.2010.97","volume":"7","author":"DL Wheeler","year":"2010","unstructured":"Wheeler DL, Dunn EF, Harari PM (2010) Understanding resistance to EGFR inhibitors-impact on future treatment strategies. Nat Rev Clin Oncol 7:493\u2013507","journal-title":"Nat Rev Clin Oncol"},{"key":"160_CR10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.molonc.2012.11.001","volume":"7","author":"NR Young","year":"2013","unstructured":"Young NR, Liu J, Pierce C et al (2013) Molecular phenotype predicts sensitivity of squamous cell carcinoma of the head and neck to epidermal growth factor receptor inhibition. Mol Oncol 7:359\u2013368","journal-title":"Mol Oncol"},{"key":"160_CR11","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/hed.21365","volume":"32","author":"ME Sharafinski","year":"2010","unstructured":"Sharafinski ME, Ferris RL, Ferrone S, Grandis JR (2010) Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neck. Head Neck 32:1412\u20131421","journal-title":"Head Neck"},{"key":"160_CR12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.gene.2005.10.018","volume":"366","author":"N Normanno","year":"2006","unstructured":"Normanno N, De Luca A, Bianco C et al (2006) Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 366:2\u201316","journal-title":"Gene"},{"key":"160_CR13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/B978-0-12-386503-8.00006-5","volume":"114","author":"A Rapisarda","year":"2012","unstructured":"Rapisarda A, Melillo G (2012) Role of the VEGF\/VEGFR axis in cancer biology and therapy. Adv Cancer Res 114:237\u2013267","journal-title":"Adv Cancer Res"},{"key":"160_CR14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijrobp.2003.11.041","volume":"59","author":"RS Herbst","year":"2004","unstructured":"Herbst RS (2004) Review of epidermal growth factor receptor biology. Int J Radiat Oncol Biol Phys 59:21\u201326","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"160_CR15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.prp.2011.03.002","volume":"207","author":"P Uribe","year":"2011","unstructured":"Uribe P, Gonzalez S (2011) Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy. Pathol Res Pract 207:337\u2013342","journal-title":"Pathol Res Pract"},{"key":"160_CR16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1742-4658.2009.07448.x","volume":"277","author":"T Mitsudomi","year":"2010","unstructured":"Mitsudomi T, Yatabe Y (2010) Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer. FEBS J 277:301\u2013308","journal-title":"FEBS J"},{"key":"160_CR17","doi-asserted-by":"crossref","first-page":"12480","DOI":"10.1073\/pnas.0803217105","volume":"105","author":"SM Rothenberg","year":"2008","unstructured":"Rothenberg SM, Engelman JA, Le S, Riese DJ 2nd, Haber DA, Settleman J (2008) Modeling oncogene addiction using RNA interference. Proc Natl Acad Sci U S A 105:12480\u201312484","journal-title":"Proc Natl Acad Sci U S A"},{"key":"160_CR18","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1007\/s11095-011-0604-5","volume":"28","author":"Z Wang","year":"2011","unstructured":"Wang Z, Rao DD, Senzer N, Nemunaitis J (2011) RNA interference and cancer therapy. Pharm Res 28:2983\u20132995","journal-title":"Pharm Res"},{"key":"160_CR19","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nmeth923","volume":"3","author":"K Chang","year":"2006","unstructured":"Chang K, Elledge SJ, Hannon GJ (2006) Lessons from nature: microRNA-based shRNA libraries. Nat Methods 3:707\u2013714","journal-title":"Nat Methods"},{"key":"160_CR20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2217\/14796694.2.1.137","volume":"2","author":"DT Rein","year":"2006","unstructured":"Rein DT, Breidenbach M, Curiel DT (2006) Current developments in adenovirus- based cancer gene therapy. Future Oncol 2:137\u2013143","journal-title":"Future Oncol"},{"key":"160_CR21","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.addr.2009.03.013","volume":"61","author":"DE Dorer","year":"2009","unstructured":"Dorer DE, Nettelbeck DM (2009) Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis. Adv Drug Deliv Rev 61:554\u2013571","journal-title":"Adv Drug Deliv Rev"},{"key":"160_CR22","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/cgt.2012.5","volume":"19","author":"J Chen","year":"2012","unstructured":"Chen J, Yang B, Zhang S et al (2012) Antitumor potential of SLPI promoter controlled recombinant caspase-3 expression in laryngeal carcinoma. Cancer Gene Ther 19:328\u2013335","journal-title":"Cancer Gene Ther"},{"key":"160_CR23","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrc1609","volume":"5","author":"NE Hynes","year":"2005","unstructured":"Hynes NE, Lane HA (2005) ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer 5:341\u2013354","journal-title":"Nat Rev Cancer"},{"key":"160_CR24","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1349-7006.2008.00772.x","volume":"99","author":"T Nukiwa","year":"2008","unstructured":"Nukiwa T, Suzuki T, Fukuhara T, Kikuchi T (2008) Secretory leukocyte peptidase inhibitor and lung cancer. Cancer Sci 99:849\u2013855","journal-title":"Cancer Sci"},{"key":"160_CR25","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1158\/0008-5472.CAN-03-2549","volume":"64","author":"M Maemondo","year":"2004","unstructured":"Maemondo M, Saijo Y, Narumi K et al (2004) Gene therapy with secretory leukoprotease inhibitor promoter-controlled replication-competent adenovirus for non-small cell lung cancer. Cancer Res 64:4611\u20134620","journal-title":"Cancer Res"},{"key":"160_CR26","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1158\/1078-0432.1327.11.3","volume":"11","author":"DT Rein","year":"2005","unstructured":"Rein DT, Breidenbach M, Kirby TO et al (2005) A fiber-modified, secretory leukoprotease inhibitor promoter-based conditionally replicating adenovirus for treatment of ovarian cancer. Clin Cancer Res 11:1327\u20131335","journal-title":"Clin Cancer Res"},{"key":"160_CR27","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2174\/156652311796150363","volume":"11","author":"R Khare","year":"2011","unstructured":"Khare R, Chen CY, Weaver EA, Barry MA (2011) Advances and future challenges in adenoviral vector pharmacology and targeting. Curr Gene Ther 11:241\u2013258","journal-title":"Curr Gene Ther"},{"key":"160_CR28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.18632\/oncotarget.231","volume":"2","author":"B Thaci","year":"2011","unstructured":"Thaci B, Ulasov IV, Wainwright DA, Lesniak MS (2011) The challenge for gene therapy: innate immune response to adenoviruses. Oncotarget 2:113\u2013121","journal-title":"Oncotarget"},{"key":"160_CR29","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/nbt1196-1574","volume":"14","author":"JT Douglas","year":"1996","unstructured":"Douglas JT, Rogers BE, Rosenfeld ME, Michael SI, Feng M, Curiel DT (1996) Targeted gene delivery by tropism-modified adenoviral vectors. Nat Biotechnol 14:1574\u20131578","journal-title":"Nat Biotechnol"},{"key":"160_CR30","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1089\/hum.2004.15.1034","volume":"15","author":"H Mizuguchi","year":"2004","unstructured":"Mizuguchi H, Hayakawa T (2004) Targeted adenovirus vectors. Hum Gene Ther 15:1034\u20131044","journal-title":"Hum Gene Ther"},{"key":"160_CR31","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1128\/JVI.79.6.3382-3390.2005","volume":"79","author":"H Wu","year":"2005","unstructured":"Wu H, Han T, Belousova N et al (2005) Identification of sites in adenovirus hexon for foreign peptide incorporation. J Virol 79:3382\u20133390","journal-title":"J Virol"},{"key":"160_CR32","doi-asserted-by":"crossref","first-page":"6831","DOI":"10.1128\/JVI.70.10.6831-6838.1996","volume":"70","author":"TJ Wickham","year":"1996","unstructured":"Wickham TJ, Segal DM, Roelvink PW et al (1996) Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies. J Virol 70:6831\u20136838","journal-title":"J Virol"},{"key":"160_CR33","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0969-2126(94)00126-X","volume":"2","author":"D Xia","year":"1994","unstructured":"Xia D, Henry LJ, Gerard RD, Deisenhofer J (1994) Crystal structure of the receptor-binding domain of adenovirus type 5 fiber protein at 1.7 a resolution. Structure 2:1259\u20131270","journal-title":"Structure"},{"key":"160_CR34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc2982","volume":"11","author":"CR Leemans","year":"2011","unstructured":"Leemans CR, Braakhuis BJ, Brakenhoff RH (2011) The molecular biology of head and neck cancer. Nat Rev Cancer 11:9\u201322","journal-title":"Nat Rev Cancer"},{"key":"160_CR35","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1634\/theoncologist.12-12-1443","volume":"12","author":"C Widakowich","year":"2007","unstructured":"Widakowich C, de Castro G Jr, de Azambuja E, Dinh P, Awada A (2007) Review: side effects of approved molecular targeted therapies in solid cancers. Oncologist 12:1443\u20131455","journal-title":"Oncologist"}],"container-title":["Pathology & Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-016-0160-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-016-0160-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-016-0160-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T22:05:13Z","timestamp":1719007513000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-016-0160-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,18]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["160"],"URL":"https:\/\/doi.org\/10.1007\/s12253-016-0160-8","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,18]]}}}